ABCL-515 Updated Results of the Safety Run-In of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL
美罗华
医学
内科学
肿瘤科
淋巴瘤
作者
Michał Kwiatek,Sebastian Grosicki,Javier López Jiménez,Sergio Felipe Pinzón Mariño,Sylvia Snauwaert,Edwin C. Kingsley,Giovanna Zacchetti,Ying Wang,Luqiang Wang,Julien Depaus